Results 211 to 220 of about 443,078 (244)

Correction to: Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial. [PDF]

Eur Heart J
europepmc   +1 more source

Quercetin in Myocardial Ischemia–Reperfusion Injury: Mechanistic Evidence, Cardioprotective Effects, and Translational Challenges

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 10, October 2026.
Quercetin mitigates myocardial ischemia–reperfusion injury through coordinated antioxidant, anti‐inflammatory, and anti‐apoptotic mechanisms, leading to reduced infarct size and improved cardiac function. Its multi‐target cardioprotective effects highlight quercetin as a promising therapeutic candidate for ischemic heart disease.
Rony Abdi Syahputra, Princella Halim, Sasniwiati Sari Hasibuan, Adhayani Lubis   +3 more
wiley   +1 more source

Intraprocedural Hemodynamics During Concomitant Rheocarna Therapy and Maintenance Hemodialysis: Effects of Dialyzer Membrane Type and Circuit Sequence

Journal of Clinical Apheresis, Volume 41, Issue 5, October 2026.
ABSTRACT Chronic limb‐threatening ischemia (CLTI), a severe manifestation of peripheral artery disease, is particularly prevalent among patients receiving maintenance hemodialysis (HD) and is associated with poor limb and survival outcomes. Low‐density lipoprotein (LDL) apheresis, including Rheocarna, is used as adjunctive therapy for refractory CLTI ...
Yusuke Ishizuka, Genshin Sato, Shizuka Ishigaki, Ryo Enoki, Kako Kajiwara, Akihiko Nakasato, Sosuke Kinomura, Saori Kin, Yuji Noguchi, Daisuke Yoshizawa, Koichi Kikuchi, Michiaki Abe, Koki Kumagai, Tetsuhiro Tanaka, Koji Okamoto   +14 more
wiley   +1 more source

2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines (Part II) on Stroke Prevention in Atrial Fibrillation

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
ABSTRACT The 2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines represent the first comprehensive APHRS guidelines dedicated to the management of atrial fibrillation (AF) and comprise four parts covering epidemiology, detection/screening and integrated care; stroke prevention; rate and rhythm control; and lifestyle risk factor and comorbidity ...
Tze‐Fan Chao, Gregory Y. H. Lip, Yi‐Hsin Chan, So‐Ryoung Lee, Mingfang Li, Daehoon Kim, Ling Kuo, Ken Okumura, Hung‐Fat Tse, Eue‐Keun Choi, Minglong Chen, Boyoung Joung, Rungroj Krittayaphong, Melissa E. Middeldorp, Kyoko Soejima, Hui‐Nam Pak   +15 more
wiley   +1 more source

Appropriate ICD Therapies in Primary Prevention: A Propensity‐Matched Comparison of Contemporary and Historic Heart Failure Cohorts

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
No significant difference in appropriate ICD therapies between treatment eras. Time to first ICD therapy was similar after propensity‐score matching. The result was robust to a sensitivity analysis using an expanded propensity model. Cumulative incidence, accounting for competing risk of death, was also higher.
Inês Ferreira Neves, Guilherme Portugal, Julien Lopes, Ana Rita Teixeira, Pedro Silva Cunha, Bruno Valente, Ana Lousinha, Rita Moreira, Hélder Santos, António Gonçalves, Rui Cruz Ferreira, Mário Martins Oliveira   +11 more
wiley   +1 more source

Neutrophil Extracellular Traps in Atherosclerosis and Cardiovascular Disease

MedComm, Volume 7, Issue 10, October 2026.
NETs as integrated effectors in the atherosclerotic cardiovascular disease continuum. Activated neutrophils release NETs that promote endothelial injury, thrombo‐inflammation, and plaque destabilization throughout atherosclerotic disease progression. Created with BioRender.com.
Ji Zhang, Fangjiaqi Wei, Mengdi Qu, Yuwen Shao, Tingye Xu, Darko Stojkov, Hans‐Uwe Simon, Ben Huang, Changhong Miao, Hao Zhang   +9 more
wiley   +1 more source

Multifunctional Hydrogels: Rational Design and Application in Regenerative Medicine

MedComm, Volume 7, Issue 10, October 2026.
Multifunctional hydrogels represent a paradigm shift in regenerative medicine, integrating rational material design with bioactive functionality to address complex tissue repair challenges. This review systematically examines the molecular engineering, structure–function relationships, and translational landscape of advanced hydrogel systems, spanning ...
Linyang Song, Epiphane K. Silli, Yazhen Xu, Huixia Lv, Ruoxian Song   +4 more
wiley   +1 more source

Movement Behaviors and Quality of Life in Cardiac Rehabilitation Programs: A Study Based on the Canadian 24‐Hour Movement Guidelines

Physiotherapy Research International, Volume 31, Issue 4, October 2026.
ABSTRACT Background and Purpose The Canadian 24‐Hour Movement Guidelines integrate recommendations on physical activity (PA), sedentary behavior (SB), and sleep. Individuals in cardiac rehabilitation programs (CRPs) have specific characteristics that may influence adherence to these 24‐Hour Movement Guidelines and their relationship with quality of ...
Júlio César de Ávila Soares, Maria Eduarda Martins Vigilato, Heloísa Balotari Valente, Alice Haniuda Moliterno, João Pedro Lucas Neves Silva, Diego Giulliano Destro Christofaro, Luiz Carlos Marques Vanderlei   +6 more
wiley   +1 more source

Circulating SCGB3A2 Is Associated With Impaired Coronary Collateralization in Patients With Chronic Total Occlusion and Type 2 Diabetes: A Proteomic Discovery and Validation Study

Journal of Diabetes, Volume 18, Issue 10, October 2026.
Proteomic profiling identified SCGB3A2 as a novel biomarker associated with impaired coronary collateralization in patients with chronic total occlusion and Type 2 diabetes. Independent validation supports its potential for risk stratification. ABSTRACT Background Type 2 diabetes mellitus (T2DM) is associated with impaired coronary collateralization in
Jian‐Jun Chen, Shuai Chen, Jia‐Kang Wang, Ke Huang, An Wang, Lin Lu, Yang Dai, Feng‐Hua Ding   +7 more
wiley   +1 more source

Development in Left Ventricular Mass After Early and Late Conversion From Calcineurin Inhibitors to Everolimus in Heart Transplant Recipients—Results From Two Randomized Controlled Trials

Clinical Transplantation, Volume 40, Issue 10, October 2026.
ABSTRACT Left ventricular hypertrophy in heart transplant recipients has been attributed to the use of calcineurin inhibitors. We assessed left ventricular mass across treatment arms in 83 heart transplant recipients in the Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE), and in 75 ...
Klaus Murbraech, Feben Tecklzig, Richard John Massey, Einar Gude, Finn Gustafsson, Hans Eiskjær, Kristjan Karason, Göran Rådegran, Arne K. Andreassen, Lars Gullestad, Kaspar Broch   +10 more
wiley   +1 more source